Search Results - "Yousef Hailan"

Refine Results
  1. 1

    Chronic Myeloid Leukemia following Exposure to Radioactive Iodine (I131): A Systematic Review by Ali Hailan, Yousef Mohammed, Al-Dubai, Husam Nabil, Yassin, Mohamed A

    Published in Oncology (01-06-2023)
    “…Therapy-related leukemia is a term that describes the occurrence of leukemia following exposure to hematotoxins and radiation to emphasize the difference from…”
    Get more information
    Journal Article
  2. 2

    SECONDARY CHRONIC MYELOID LEUKEMIA FOLLOWING RADIOACTIVE IODINE (I131) by Yousef Hailan, Mohamed Yassin

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Objective: Radioactive iodine (RAI) with I131 has an established role in managing differentiated thyroid carcinoma, namely papillary thyroid carcinoma (PTC)…”
    Get full text
    Journal Article
  3. 3

    Endomyocardial fibrosis in a non‐tropical patient who presented with chest pain mimicking ACS and left ventricular thrombus, case report by Matarneh, Ahmad S., Hailan, Yousef M. Ali, Abdul Karim, Sabir, Al Kuwari, Maryam A., Dabdoob, Wafer A.

    Published in Clinical case reports (01-05-2022)
    “…Endomyocardial fibrosis (EMF) is a disease known to cause restrictive cardiomyopathy. It shows a high prevalence in tropical countries. Several triggering…”
    Get full text
    Journal Article
  4. 4

    Chronic Myeloid Leukemia in a Patient with Hepatitis B Virus Infection: A Case Report by Ali Hailan, Yousef Mohammed, Mudawi, Deena, Yassin, Mohamed A.

    Published in Case reports in oncology (24-06-2021)
    “…Chronic myeloid leukemia (CML) is a myeloproliferative disorder diagnosed by demonstrating the Philadelphia chromosome (Ph) or the BCR-ABL fusion gene…”
    Get full text
    Journal Article
  5. 5

    Pediatric Philadelphia-Negative Myeloproliferative Neoplasms in the Era of WHO Classification: A Systematic Review by Al-Mashdali, Abdulrahman F, Aldapt, Mahmood B, Rahhal, Alaa, Hailan, Yousef M, Elhakeem, Israa, Ali, Elrazi A, Rozi, Waail, Yassin, Mohamed A

    Published in Diagnostics (Basel) (19-01-2023)
    “…Philadelphia-negative myeloproliferative neoplasms (MPN) are most prevalent in the older population (median age at the diagnosis is above 60 years) and rarely…”
    Get full text
    Journal Article
  6. 6

    DIRECT ORAL ANTICOAGULANTS IN SICKLE CELL DISEASE, WHERE WE STAND AND WHERE WE ARE HEADING: A SYSTEMATIC REVIEW by Waail Rozi, Abdulrahman Al-Mashdali, Elrazi Ali, Alaa Rahhal, Yousef Hailan, Mohamed Yassin

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Objective: The evidence guiding VTE management in SCD, specifically in terms of anticoagulant choice, is scarce. Therefore, we conducted a systematic review…”
    Get full text
    Journal Article
  7. 7

    The Impact of Tyrosine Kinase Inhibitors on Fatherhood in Patients With Chronic Myeloid Leukemia: A Mixed-Method Study by Abu-Tineh, Mohammad, Ali, Elrazi A, Alshurafa, Awni, Nashwan, Abdulqadir J, Albsheer, Khalid, Ahmed, Ashraf, Hailan, Yousef, Rozi, Waail, Aljaloudi, Esraa, Yassin, Mohamed A

    Published in Curēus (Palo Alto, CA) (05-01-2023)
    “…Multiple studies have demonstrated that tyrosine kinase inhibitors (TKIs) exert a significant extent of control over chronic myeloid leukemia (CML), as…”
    Get full text
    Journal Article
  8. 8

    THE OUTCOME OF FATHERHOOD IN PATIENTS WITH PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE NEOPLASMS, A SINGLE INSTITUTION EXPERIENCE by Elrazi Ali, Mohammad Abu-Tineh, Anas Babiker, Yousef Hailan, Bashir Ali, Qusai Maharmah, Zakaria Maat, Abdulatif Waggad, Mohamed Yassin

    Published in Hematology, Transfusion and Cell Therapy (01-11-2021)
    “…Objective: The aim of this retrospective study is to evaluate fertility in the Philadelphia-negative MPN male patients and the effect of treatment received on…”
    Get full text
    Journal Article
  9. 9

    The Outcome of Fatherhood in Patients With Philadelphia-Negative Myeloproliferative Neoplasms: A Single-Institution Experience by Ali, Elrazi A, Abu-Tineh, Mohammad, Rozi, Waail, Ali, Bashir, Babiker, Anas, Hailan, Yousef, Al-Maharmeh, Qusai, Maat, Zakaria, Ismail, Abdellatif, Yassin, Mohamed A

    Published in Curēus (Palo Alto, CA) (15-06-2022)
    “…BackgroundFertility is a highly complex subject; it involves more than one individual and has profound psychological and economic implications. Moreover, it is…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    COVID‐19 in a pregnant patient with beta‐thalassemia major: A case report by Hailan, Yousef Mohammed Ali, Sayed, Gamal, Yassin, Mohamed A.

    Published in Clinical case reports (01-07-2021)
    “…Further studies are needed on this unique population to better manage them and increase their chances of normal pregnancy and fewer complications and more…”
    Get full text
    Journal Article
  13. 13

    Chronic Myeloid Leukemia Following Exposure to Radioactive Iodine (I 131): A Systematic Review by Hailan, Yousef Mohammed, Yassin, Mohamed A

    Published in Blood (23-11-2021)
    “…Introduction Therapy-related leukemia or secondary leukemia are the terms that describe the occurrence of leukemias following exposure to hematotoxins and…”
    Get full text
    Journal Article
  14. 14

    Acute hemolysis and methemoglobinemia secondary to fava beans ingestion in a patient with G6PD deficiency: A case report of a rare co-occurrence by Al-Dubai, Husam, Al-Mashdali, Abdulrahman, Hailan, Yousef

    Published in Medicine (Baltimore) (24-11-2021)
    “…Favism is a well-known cause of acute hemolytic anemia. Rarely, methemoglobinemia can also happen because of fava bean ingestion in patients with…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Direct Oral Anticoagulants in Sickle Cell Disease, Where We Stand and Where We Are Heading: A Systematic Review by Kashgary, Waail Rozi, Ali, Elrazi Awadelkarim Awadelkarim Hamid, Rahhal, Alaa, Al-Mashdali, Abdulrahman F, Hailan, Yousef, Yassin, Mohamed A

    Published in Blood (23-11-2021)
    “…Introduction: Sickle Cell Disease (SCD) is a hemolytic disorder with an increased risk of venous thromboembolism (VTE). By the age of 40 years around 11-12% of…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20